Cargando…
Identification of Immuno-Targeted Combination Therapies Using Explanatory Subgroup Discovery for Cancer Patients with EGFR Wild-Type Gene
SIMPLE SUMMARY: Cancer immunotherapy is a form of cancer treatment that uses a person’s own immune system to prevent, control, and eliminate cancer. However, immunotherapy alone may not be effective, especially in patients with limited treatment options. Immuno-targeted combination therapies have a...
Autores principales: | Kholod, Olha, Basket, William, Liu, Danlu, Mitchem, Jonathan, Kaifi, Jussuf, Dooley, Laura, Shyu, Chi-Ren |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9564073/ https://www.ncbi.nlm.nih.gov/pubmed/36230688 http://dx.doi.org/10.3390/cancers14194759 |
Ejemplares similares
-
Immune-Related Gene Signatures to Predict the Effectiveness of Chemoimmunotherapy in Triple-Negative Breast Cancer Using Exploratory Subgroup Discovery
por: Kholod, Olha, et al.
Publicado: (2022) -
Exploratory Data Mining for Subgroup Cohort Discoveries and Prioritization
por: Liu, Danlu, et al.
Publicado: (2020) -
Drug Repositioning and Subgroup Discovery for Precision Medicine Implementation in Triple Negative Breast Cancer
por: Al-Taie, Zainab, et al.
Publicado: (2021) -
Current and Prospective Methods for Assessing Anti-Tumor Immunity in Colorectal Cancer
por: Nussbaum, Yulia I., et al.
Publicado: (2021) -
TBX21 Methylation as a Potential Regulator of Immune Suppression in CMS1 Subtype Colorectal Cancer
por: Shen, Yuanyuan, et al.
Publicado: (2022)